We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

By LabMedica International staff writers
Posted on 14 Apr 2025

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. More...

Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared light to identify molecular signatures in blood plasma that may indicate the presence of certain cancers. In this proof-of-concept study, blood plasma samples from over 2,000 individuals were analyzed to correlate specific molecular patterns with lung cancer, suggesting the possibility of a unique "cancer fingerprint."

Blood plasma, the liquid component of blood, is free of cells and transports various molecules, including proteins, metabolites, lipids, and salts throughout the body. Certain molecules within plasma can serve as biomarkers for potential health issues. For example, elevated levels of prostate-specific antigen are used for prostate cancer screening. A medical test that could analyze a wide range of molecules might be capable of identifying specific patterns associated with different types of cancer, enabling faster diagnoses and reducing healthcare costs. To identify potential chemical markers of cancer, researchers from Ludwig Maximilian University of Munich (Munich, Germany) employed a method called electric-field molecular fingerprinting, which uses pulsed infrared light to analyze complex molecular mixtures in blood plasma.

In their study, the researchers applied this technique by directing ultra-short infrared light pulses through plasma samples. They then analyzed data from 2,533 participants, including individuals with lung, prostate, breast, or bladder cancer, as well as healthy controls. For each sample, they captured the "infrared molecular fingerprint," which represents the light emitted by the molecular components of the plasma. By examining these diverse molecular patterns from both cancer patients and non-cancer controls, the researchers trained a machine learning model to identify specific molecular signatures associated with the four cancer types. The model was tested on a separate set of samples to assess its ability to recognize new, unseen data. The technique achieved up to 81% accuracy in detecting lung cancer-related molecular patterns and distinguishing them from non-cancer samples. However, the model's performance was less effective in identifying the other three types of cancer. Moving forward, the researchers plan to refine and expand their approach to detect additional cancers and other health conditions.

"Laser-based infrared molecular fingerprinting detects cancer, demonstrating its potential for clinical diagnostics,” said LMU Munich researcher Mihaela Žigman. “With further technological developments and independent validation in sufficiently powered clinical studies, it could establish generalizable applications and translate into clinical practice — advancing the way we diagnose and screen for cancer today.”


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Multilevel Whole Blood Calibrator Set
6PLUS1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Pathology

view channel
Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.